Investors Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
GSK investor event
We announced our second quarter 2017 results and hosted an investor event on 26 July. At the investor event Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our key priorities and financial outlook.
Investor event
Watch the investor event videos
Emma Walmsley presentation: Key priorities
Simon Dingemans presentation: Q2 and financial outlook
Investor event full transcript
Our new business priorities
At the investor event we set out our new business priorities - centred around Innovation, Performance and Trust - which we will implement from 2018 onwards.
See our new business priorities
Latest information
Latest press releases
- GSK delivers further progress in Q2 and sets out new priorities for the Group
- Karenann Terrell appointed Chief Digital & Technology Officer, GSK
- ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
Annual Report and Responsible Business Supplement 2016
View our Annual Report 2016 summary and download the full Annual Report and Responsible Business Supplement.